Praxis Precision Medicines, Inc.
PRAX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689548
No open-market purchases or sales by Praxis Precision Medicines, Inc. insiders were filed in the last 90 days; 309 institutions reported holding it in 13F filings for Q2 2026, worth $11.3B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Praxis Precision Medicines, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 80 | 93 | +13 |
| Shares | 41.2M | 42.8M | +1.64M (+4.0%) |
| Value | $751.0M | $791.5M | +$40.5M (+5.4%) |
New holders (22)
Institutions that held Praxis Precision Medicines, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (9)
Institutions that held Praxis Precision Medicines, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Monashee Investment Management LLC | 100,000 | $1.83M |
| Sphera Funds Management Ltd. | 75,600 | $1.38M |
| Alyeska Investment Group, L.P. | 75,000 | $1.37M |
| D. E. Shaw & Co., Inc. | 45,264 | $827.0K |
| Renaissance Technologies LLC | 37,400 | $684.0K |
| Los Angeles Capital Management LLC | 17,600 | $322.0K |
| Squarepoint Ops LLC | 17,427 | $319.0K |
| STRS Ohio | 2,700 | $49.0K |
| O'Shaughnessy Asset Management, LLC | 1,004 | $18.0K |